Bristol-Myers Squibb buy Guggenheim
Start price
23.12.25
/
50%
€46.50
Target price
23.12.26
-
Performance (%)
8.54%
Price
17:44
€50.47
Summary
This prediction is currently active. The BUY prediction by Guggenheim shows slight gains of 8.54%. This prediction currently runs until 23.12.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | -4.840% | -4.840% |
| iShares Core DAX® | 3,01 % | 1,44 % |
| iShares Nasdaq 100 | 3,01 % | 0,57 % |
| iShares Nikkei 225® | 4,14 % | 4,55 % |
| iShares S&P 500 | 2,38 % | 0,24 % |
Comments by Guggenheim for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for BMY provided by MarketBeat